Hemostasis Achievement Reflecting Inflammatory Status of the Pulp Based on Cytokine Levels: A Cohort Study.
1 other identifier
observational
41
1 country
1
Brief Summary
Assessment of pulp inflammation by hemostasis achievement after pulp exposure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2018
CompletedFirst Posted
Study publicly available on registry
November 9, 2018
CompletedStudy Start
First participant enrolled
July 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 14, 2023
CompletedAugust 15, 2024
August 1, 2024
4 years
October 31, 2018
August 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Measuring interleukin 2 (IL-2)
to measure cytokines levels after coronal pulpal removal
After 5 minutes
Secondary Outcomes (2)
Measuring interleukin 6 (IL-6) and interleukin 8 (IL-8)
After 5 minutes
Postoperative pain, Bifurcation/periapical radiolucency and Internal/external root resorption Or other pathological changes
3,6,9,12 months
Study Arms (2)
hemostasis achievement
in which hemostasis at the exposure site was achieved in five minutes were included in group A
No hemostasis achievement
in which hemostasis at the exposure site couldn't be achieved in five minutes where included in group B
Interventions
Hemostasis achievement reflecting inflammatory status of the pulp based on cytokine levels
Eligibility Criteria
* primary teeth with carious pulp exposures during caries removal will be included in the study. * primary molars with the presence of exudate, purulence or necrotic pulp tissue around the exposure site will be excluded
You may qualify if:
- healthy children
- patients had not used any inflammatory medications
- primary molar teeth of these children were included based on the following clinical and radiographic criteria:
- no clinical symptoms or evidence of pulp degeneration (pain on percussion, history of swelling or sinus tract
- no spontaneous pain
- no radiographic signs of internal or external resorption, widened periodontal ligament space, or furcal/periapical radiolucency
- physiological root resorption of no more than one third the root length
- a deep caries lesion with a likelihood of pulp exposure during caries removal
You may not qualify if:
- patients used any anti-inflammatory medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo university
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
October 31, 2018
First Posted
November 9, 2018
Study Start
July 30, 2019
Primary Completion
August 14, 2023
Study Completion
August 14, 2023
Last Updated
August 15, 2024
Record last verified: 2024-08